The Europe Kyphoplasty Market would witness market growth of 5.8% CAGR during the forecast period (2022-2028).
A wide variety of bone cement has so far been authorized for use in clinical settings, and several of them have been applied during balloon kyphoplasty procedures. The development of balloon kyphoplasty cement's new technological advancements is dependent on cutting-edge ideas and interdisciplinary expertise. The balloon kyphoplasty indications will probably be expanded with the introduction of innovative biodegradable & mechanically matched bone cement, supporting segment expansion. A major trend in the kyphoplasty market has been proven to be the inclination for less intrusive procedures.
Furthermore, rising healthcare spending, increasing demand for minimally invasive orthopedic surgery, & better health reimbursements are predicted to propel market expansion throughout projected period. The rise of the kyphoplasty market is also projected to be fueled by an increase in the frequency of spine fractures. By increasing price transparency, holding hospitals responsible, & ensuring that consumers have access to the information they need to make fully informed decisions about their health care, CMS is concentrating its efforts.
Due to the continued acceptance of better and more expensive kyphoplasty devices, the market for these systems in Europe, namely in Germany and Italy, is anticipated to expand at the quickest rate throughout the forecast period. One of the surgical specialties in the Europe region that is evolving the fastest is likely spine surgery. It combines as the "bastard offspring" of neurosurgery and orthopedics. Being the result of two specializations has challenges, but it also provides numerous opportunities.
The Germany market dominated the Europe Kyphoplasty Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $55.6 million by 2028. The UK market is anticipated to grow at a CAGR of 5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 6.6% during (2022 - 2028).
Based on Product Type, the market is segmented into Accessories and Kyphoplasty Systems. Based on Indication, the market is segmented into Osteoporosis and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Kyphoplasty Market will Hit $837.1 Million by 2028, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, MicroPort Scientific Corporation, IZI Medical Products, LLC (Landauer, Inc.), Merit Medical Systems, Inc., Jiangsu Changmei Medtech Co. Ltd., G21 S.r.l., Seawon Meditech Co., Ltd., joimax® GmbH and Taeyeon medical Co., Ltd.
By Product Type
By Indication
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 